These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 27581151)
1. An Integrative Analysis of microRNA and mRNA Profiling in CML Stem Cells. Nassar FJ; El Eit R; Nasr R Methods Mol Biol; 2016; 1465():219-41. PubMed ID: 27581151 [TBL] [Abstract][Full Text] [Related]
2. Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted "hsa-miR-2278" as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A. Kaymaz BT; Günel NS; Ceyhan M; Çetintaş VB; Özel B; Yandım MK; Kıpçak S; Aktan Ç; Gökbulut AA; Baran Y; Can BK Tumour Biol; 2015 Sep; 36(10):7915-27. PubMed ID: 25953263 [TBL] [Abstract][Full Text] [Related]
3. Identification and functional characterization of the miRNA-gene regulatory network in chronic myeloid leukemia lineage negative cells. Agatheeswaran S; Pattnayak NC; Chakraborty S Sci Rep; 2016 Sep; 6():32493. PubMed ID: 27586591 [TBL] [Abstract][Full Text] [Related]
4. miRNome Analysis of CML Cells. Yang Y; Ding N; Dong X; Fang X Methods Mol Biol; 2016; 1465():207-17. PubMed ID: 27581150 [TBL] [Abstract][Full Text] [Related]
5. miRNA and mRNA expression profiling in rat brain following alcohol dependence and withdrawal. Sinirlioglu ZA; Coskunpinar E; Akbas F Cell Mol Biol (Noisy-le-grand); 2017 Feb; 63(2):49-56. PubMed ID: 28364783 [TBL] [Abstract][Full Text] [Related]
6. Deciphering the cross-talking of human competitive endogenous RNAs in K562 chronic myelogenous leukemia cell line. Sen K; Sarkar A; Maji RK; Ghosh Z; Gupta S; Ghosh TC Mol Biosyst; 2016 Nov; 12(12):3633-3642. PubMed ID: 27730241 [TBL] [Abstract][Full Text] [Related]
7. Posttranscriptional regulatory networks: from expression profiling to integrative analysis of mRNA and microRNA data. Meyer SU; Stoecker K; Sass S; Theis FJ; Pfaffl MW Methods Mol Biol; 2014; 1160():165-88. PubMed ID: 24740230 [TBL] [Abstract][Full Text] [Related]
8. Expression pattern of key microRNAs in patients with newly diagnosed chronic myeloid leukemia in chronic phase. Fallah P; Amirizadeh N; Poopak B; Toogeh G; Arefian E; Kohram F; Hosseini Rad SM; Kohram M; Teimori Naghadeh H; Soleimani M Int J Lab Hematol; 2015 Aug; 37(4):560-8. PubMed ID: 25833191 [TBL] [Abstract][Full Text] [Related]
9. Selective miRNA expression profile in chronic myeloid leukemia K562 cell-derived exosomes. Feng DQ; Huang B; Li J; Liu J; Chen XM; Xu YM; Chen X; Zhang HB; Hu LH; Wang XZ Asian Pac J Cancer Prev; 2013; 14(12):7501-8. PubMed ID: 24460325 [TBL] [Abstract][Full Text] [Related]
10. Integrated analysis of mRNA, microRNA and protein in systemic lupus erythematosus-specific induced pluripotent stem cells from urine. Tang D; Chen Y; He H; Huang J; Chen W; Peng W; Lu Q; Dai Y BMC Genomics; 2016 Jul; 17():488. PubMed ID: 27402083 [TBL] [Abstract][Full Text] [Related]
11. Construction and Analysis of miRNA Regulatory Networks. Mensi A; Bonnici V; Caligola S; Giugno R Methods Mol Biol; 2019; 1970():121-167. PubMed ID: 30963492 [TBL] [Abstract][Full Text] [Related]
12. Expression analysis of PCNA gene in chronic myelogenous leukemia--combined application of siRNA silencing and expression arrays. Merkerova M; Bruchova H; Brdicka R Leuk Res; 2007 May; 31(5):661-72. PubMed ID: 17070905 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia. Zhao L; Li Y; Song X; Zhou H; Li N; Miao Y; Jia L Oncotarget; 2016 Sep; 7(37):60074-60086. PubMed ID: 27527856 [TBL] [Abstract][Full Text] [Related]
14. Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase. Diaz-Blanco E; Bruns I; Neumann F; Fischer JC; Graef T; Rosskopf M; Brors B; Pechtel S; Bork S; Koch A; Baer A; Rohr UP; Kobbe G; von Haeseler A; Gattermann N; Haas R; Kronenwett R Leukemia; 2007 Mar; 21(3):494-504. PubMed ID: 17252012 [TBL] [Abstract][Full Text] [Related]
15. [Progress of study on microRNA and chronic myeloid leukemia]. Liu H; Liu Y; Liu QF Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):192-5. PubMed ID: 22391195 [TBL] [Abstract][Full Text] [Related]
16. Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells. Ohmine K; Ota J; Ueda M; Ueno S; Yoshida K; Yamashita Y; Kirito K; Imagawa S; Nakamura Y; Saito K; Akutsu M; Mitani K; Kano Y; Komatsu N; Ozawa K; Mano H Oncogene; 2001 Dec; 20(57):8249-57. PubMed ID: 11781839 [TBL] [Abstract][Full Text] [Related]
17. The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence. Bruns I; Czibere A; Fischer JC; Roels F; Cadeddu RP; Buest S; Bruennert D; Huenerlituerkoglu AN; Stoecklein NH; Singh R; Zerbini LF; Jäger M; Kobbe G; Gattermann N; Kronenwett R; Brors B; Haas R Leukemia; 2009 May; 23(5):892-9. PubMed ID: 19158832 [TBL] [Abstract][Full Text] [Related]
18. Human microRNA target identification by RRSM. Hsieh WJ; Wang H J Theor Biol; 2011 Oct; 286(1):79-84. PubMed ID: 21736879 [TBL] [Abstract][Full Text] [Related]
19. The impact of gene profiling in chronic myeloid leukaemia. Yong AS; Melo JV Best Pract Res Clin Haematol; 2009 Jun; 22(2):181-90. PubMed ID: 19698927 [TBL] [Abstract][Full Text] [Related]
20. Integrated Analysis of miRNA and mRNA Expression Profiles to Identify miRNA Targets. Li Z; Tzeng CM Methods Mol Biol; 2018; 1720():141-148. PubMed ID: 29236256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]